Literature DB >> 9747760

Molecular variation of meningococcal serotype 4 antigen genes.

R Urwin1, I M Feavers, D M Jones, M C Maiden, A J Fox.   

Abstract

Changes in the frequency of serogroup B non serotypable (B:NT) meningococci isolated in England and Wales were investigated by T-track fingerprint analysis, DNA nucleotide sequence determination, and serotyping by whole cell ELISA and dot blot assay. Seventy-three per cent of the isolates designated as B:NT by the Meningococcal Reference Unit (MRU) dot blot assay during 1993-4, expressed variants of the serotyping antigen, PorB, that were serotype 4 by whole cell ELISA. T-track fingerprint patterns of these and other 'serotype 4' isolates revealed five distinct porB alleles which were shown by nucleotide sequence determination to encode different peptide sequences. Differential binding of the 'serotype 4' mAbs MN14G21 and 5DC4C8G8 in whole cell ELISA and dot blot assays was the result, (i) of differences in the peptide sequence of predicted surface loop I and (ii) an amino acid deletion in predicted loop VI of the PorB protein.

Mesh:

Substances:

Year:  1998        PMID: 9747760      PMCID: PMC2809479          DOI: 10.1017/s0950268898008942

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

1.  Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak.

Authors:  I M Feavers; S J Gray; R Urwin; J E Russell; J A Bygraves; E B Kaczmarski; M C Maiden
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

Authors:  Rachel Urwin; Joanne E Russell; Emily A L Thompson; Edward C Holmes; Ian M Feavers; Martin C J Maiden
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Evaluation of porB PCR-amplicon restriction endonuclease analysis as a method to determine porB variable-region sequences in nonserotypeable meningococci.

Authors:  Kristin H Dyet; Robin S Simmonds; Diana R Martin
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.

Authors:  Kristin H Dyet; Diana R Martin
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

Review 5.  Molecular techniques for the investigation of meningococcal disease epidemiology.

Authors:  M C Maiden; M Frosch
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

6.  Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.

Authors:  Lee H Harrison; Kathleen A Shutt; Susanna E Schmink; Jane W Marsh; Brian H Harcourt; Xin Wang; Anne M Whitney; David S Stephens; Amanda A Cohn; Nancy E Messonnier; Leonard W Mayer
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

7.  Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts.

Authors:  G Tzanakaki; R Urwin; M Musilek; P Kriz; J Kremastinou; A Pangalis; C C Blackwell; M C Maiden
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

8.  Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil.

Authors:  Ana Paula S Lemos; Lee H Harrison; Melina Lenser; Claudio T Sacchi
Journal:  J Infect       Date:  2010-01-06       Impact factor: 6.072

9.  Population genetic and evolutionary approaches to analysis of Neisseria meningitidis isolates belonging to the ET-5 complex.

Authors:  J A Bygraves; R Urwin; A J Fox; S J Gray; J E Russell; I M Feavers; M C Maiden
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

10.  Heterogeneity of the PorB protein in serotype 22 Neisseria meningitidis.

Authors:  R Urwin; A J Fox; M Musilek; P Kriz; M C Maiden
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.